AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
ARK Invest's Latest Portfolio Adjustments: Wood Sells Roku, Invests in CRISPR and Intellia
ByAinvest
Tuesday, Aug 26, 2025 1:13 am ET1min read
Cathie Wood's ARK Invest ETFs sold 141,194 shares of Roku for $13.3 million and invested $13 million in CRISPR Therapeutics and $3.8 million in Intellia Therapeutics. Wood has been trimming Roku's position in recent days and has been accumulating shares in biotech companies. The ETFs also bought shares of PagerDuty for $1.5 million.
ARK Invest ETFs, managed by Cathie Wood, have been making significant adjustments to their portfolio, signaling a strategic pivot towards innovative healthcare solutions. On Monday, August 25, 2025, the firm sold 141,194 shares of Roku Inc (NASDAQ:ROKU) for $13,303,298, marking a substantial reduction in its position in the streaming device company [1]. This move follows a trend of trimming Roku's shares over recent days.On the buying side, ARK made notable investments in CRISPR Therapeutics AG (NASDAQ:CRSP) and Intellia Therapeutics Inc (NASDAQ:NTLA). The firm acquired 188,879 shares of CRISPR, valued at $10,259,907, and 359,000 shares of Intellia, worth $3,776,680. These purchases indicate a strong bullish stance on the gene-editing companies, reflecting ARK’s growing emphasis on the biotechnology sector [1].
Additionally, ARK purchased 90,214 shares of PagerDuty Inc (NYSE:PD) for $1,508,378, continuing its trend of accumulating shares in the cloud computing firm [1]. The consistent buying of PagerDuty shares suggests ARK's confidence in the company’s prospects.
ARK also made smaller adjustments to its portfolio, selling 1,045 shares of Guardant Health Inc (NASDAQ:GH) for $64,163 [1]. This sale is part of a series of recent sales of GH shares, indicating a gradual reduction in the ETF’s holdings in the precision oncology company.
Overall, ARK’s trades reflect a strategic shift towards companies involved in gene editing and therapeutics, while gradually reducing exposure to certain tech companies. Investors following ARK’s movements may interpret these trades as a sign of Wood’s evolving focus on innovative healthcare solutions.
References:
1. https://www.investing.com/news/company-news/cathie-woods-ark-shifts-focus-buys-crsp-stock-sells-roku-93CH-4209981
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet